Treatment of Cerebral Salt Wasting

Immediate Management Priorities

The American College of Neurosurgery recommends cerebral salt wasting treatment with aggressive volume and sodium replacement with isotonic or hypertonic saline, and fludrocortisone should be strongly considered as an adjunctive therapy to reduce ongoing sodium losses 1, 2, 3
The cornerstone of CSW treatment is recognizing that this is a hypovolemic hyponatremia requiring volume expansion, which is the opposite approach from SIADH 1, 2, 3
Fluid restriction in CSW will worsen outcomes and potentially precipitate cerebral ischemia 1, 2, 3

Administer isotonic saline (0.9% NaCl) for initial volume resuscitation to restore intravascular volume and correct hypovolemia 2, 3
For severe symptomatic hyponatremia or sodium <120 mmol/L, use 3% hypertonic saline with an initial goal to correct 6 mmol/L over 6 hours or until severe symptoms resolve 1, 2, 4
Aggressive volume resuscitation with crystalloid or colloid agents can ameliorate the risk of cerebral ischemia, particularly important in subarachnoid hemorrhage patients 5, 3

Total sodium correction must not exceed 8 mmol/L in 24 hours to prevent osmotic demyelination syndrome 1, 2, 3, 4

Fludrocortisone (a mineralocorticoid) has demonstrated substantial benefit in managing CSW and should be strongly considered, especially when sodium losses persist despite aggressive saline replacement 1, 2, 3

Hydrocortisone may be used to prevent natriuresis in subarachnoid hemorrhage patients, though fludrocortisone is more commonly studied 1, 2, 3

The treatment approaches are diametrically opposed, making accurate diagnosis essential 2, 3, 4
Volume status is the critical differentiator: CSW presents with hypovolemia while SIADH is euvolemic 2, 3

Hyponatremia in subarachnoid hemorrhage patients at risk of vasospasm should NOT be treated with fluid restriction 1, 2, 3
Maintenance of normovolemia or slight hypervolemia is required to prevent vasospasm-related cerebral ischemia 5, 1
Hypertonic saline increases regional cerebral blood flow, brain tissue oxygen, and pH in high-grade subarachnoid hemorrhage 3
Fludrocortisone may be considered specifically to prevent vasospasm in this population 1, 2, 3

Check serum sodium every 2 hours initially during active correction, then every 4 hours after severe symptoms resolve 2, 4
Monitor daily weights, fluid balance, and urine output to assess volume status 3
Track urine sodium concentration to gauge ongoing renal losses 3
Watch for signs of osmotic demyelination syndrome typically occurring 2-7 days after rapid correction 2

Using fluid restriction in CSW worsens outcomes and can precipitate cerebral ischemia 1, 2, 3
Failing to distinguish CSW from SIADH leads to inappropriate treatment with potentially catastrophic consequences 2, 3, 4
Inadequate monitoring during active correction can result in overcorrection and osmotic demyelination syndrome 1, 2
Correcting sodium too rapidly (>8 mmol/L in 24 hours) risks osmotic demyelination syndrome 1, 2, 3, 4